Proton MR Spectroscopy of Tumefactive Demyelinating Lesions
AJNR 23:1378-1386, Saindane,A.M.,et al, 2002
Multiple Sclerosis Masquerading as a Mass Lesion
Neuroradiolgoy 34:150-154, Giang,D.W.,et al, 1992
Oligoclonal IgG Bands in Cerebrospinal Fluid in Various Neurological Diseases
Ann Neurol 13:434-439, Chu,A.B.,et al, 1983
Clinicopath Conf
Distinguishing Acute Disseminated Encephalomyelitis from Multiple Sclerosis, BMJ 313:802-8041996., , 1996
A Diagnostic Index of Active Demyelination:Myelin Basic Protein in Cerebrospinal Fluid
Ann Neurol 8:25-31, Cohen,S.R.,et al, 1980
Multiple Sclerosis:Diagnostic Usefulness of Cerebrospinal Fluid
Ann Neurol 2:425, Johnson,K.,et al, 1977
A Blood Test for Multiple Sclerosis Based on the Adherence of Lymphocytes to Measles-Infected Cells
NEJM 294:1423, Levy,N.L.,et al, 1976
Prodromal Symptoms of Multiple Sclerosis in Primary Care
Ann Neurol 83:1162-1173, Disanto,G.,et al, 2018
Differentiation of Multiple Sclerosis from Other Inflammatory Disorders and Cerebrovascular Disease: Value of Spinal MR Imaging
Radiology 223:46-56, Bot,J.C.J.,et al, 2002
Antibodies to Oligodendroglia in Patient with Multiple Sclerosis
NEJM 297:1207, Abramsky,O.,et al, 1977
Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis
JAMA Neurol 76:1446-1456, Sinnecker, T.,et al, 2019
Value of the Central Vein Sign at 3T to Differentiate MS from Seropositive NMOSD
Neurol 90:e1183-e1190, Cortese, R.,et al, 2018
What Went Wrong in the Natalizumab Trials?
Lancet 367:706-709, Langer-Gould,A.&Steinman,L., 2006